TONY DICKEN: Open Payments
NPI 1124620364 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 95 payments from 15 companies in 2025. Trend: 2023 $1,329 · 2024 $1,237 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $508 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $118 |
| Braeburn Inc. | 7 | $112 |
| Alkermes, Inc. | 6 | $106 |
| Axsome Therapeutics, Inc. | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 4 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| Bausch Health US, LLC | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Lundbeck LLC | 2 | $34 |
Products named: VRAYLAR, CAPLYTA, BRIXADI, ARISTADA, Auvelity, SPRAVATO, INGREZZA, REXULTI.
Industry payments across NJ — which companies pay providers there.
